Position in TAK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$33,902,039
-$2,602,251 QoQ
Shares Held
2,114,912
+7.3% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#11
of 376 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $670,557,120 across 30 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
923,125 | $155,583,487 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
249,056 | $134,946,012 | |
| 3 | ALKS |
Alkermes plc.
|
2,421,016 | $126,861,238 | |
| 4 | ZTS |
Zoetis Inc.
|
1,435,652 | $103,165,952 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
2,114,912 | $33,902,039 | |
| 6 | LQDA |
Liquidia Corp
|
301,432 | $24,033,173 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,120,469 | $11,204,690 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
614,206 | $10,631,905 |
All Filings in TAK
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,902,039 | 2,114,912 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $36,504,290 | 1,971,074 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $37,145,186 | 2,382,629 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $36,855,306 | 2,517,439 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $40,223,951 | 2,601,808 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $40,981,050 | 2,755,955 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $42,909,939 | 3,240,932 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $45,194,203 | 3,178,214 | Shares | Sole | 2024-11-13 | |
| 2023-09-30 | $3,606,350 | 233,119 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,592,982 | 165,053 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,736,414 | 408,763 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,569,654 | 228,824 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $3,679,576 | 283,699 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,637,313 | 330,293 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,283,558 | 787,958 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,381,813 | 835,056 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $30,810,698 | 1,880,995 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $25,996,812 | 1,544,671 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $33,968,292 | 1,860,257 | Shares | Sole | 2021-05-14 | |
| 2020-06-30 | $25,035,121 | 1,396,270 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $21,856,573 | 1,439,827 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||